Anti-programmed cell death protein 1 (PD-1) antibody nivolumab leads to a dramatic and rapid response in papillary renal cell carcinoma with sarcomatoid and rhabdoid features

Research output: Contribution to journalLetterpeer-review

52 Scopus citations
Original languageEnglish
Pages (from-to)912-914
Number of pages3
JournalEuropean Urology
Volume68
Issue number5
DOIs
StatePublished - Nov 1 2015

Keywords

  • Adult
  • Antibodies, Monoclonal/therapeutic use
  • Antineoplastic Agents/therapeutic use
  • Bone Neoplasms/diagnostic imaging
  • Carcinoma, Renal Cell/diagnostic imaging
  • Humans
  • Kidney Neoplasms/diagnostic imaging
  • Lung Neoplasms/diagnostic imaging
  • Male
  • Nivolumab
  • Radiography

Fingerprint

Dive into the research topics of 'Anti-programmed cell death protein 1 (PD-1) antibody nivolumab leads to a dramatic and rapid response in papillary renal cell carcinoma with sarcomatoid and rhabdoid features'. Together they form a unique fingerprint.

Cite this